Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
4.740
+0.050 (1.07%)
At close: May 27, 2026, 4:00 PM EDT
4.740
0.00 (0.00%)
After-hours: May 27, 2026, 7:26 PM EDT
Nuvation Bio Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Nuvation Bio stock has a consensus rating of "Strong Buy" and an average price target of $12.33. The average 1-year stock price forecast is 160.13% higher than the current stock price, while the lowest is $7.00 (+47.68%) and the highest is $20 (+321.94%).
Price Target: $12.33 (+160.13%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Nuvation Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $11 | Buy | Maintains | $11 | +132.07% | May 5, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $10 → $12 | Buy | Maintains | $10 → $12 | +153.16% | May 5, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $12 | Buy | Maintains | $12 | +153.16% | May 5, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $20 | Buy | Maintains | $20 | +321.94% | May 5, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $17 | Buy | Reiterates | $17 | +258.65% | May 5, 2026 |
Financial Forecast
Revenue This Year
207.45M
from 62.90M
Increased by 229.80%
Revenue Next Year
295.90M
from 207.45M
Increased by 42.64%
EPS This Year
-0.47
from -0.60
EPS Next Year
-0.24
from -0.47
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 233.6M | 380.7M | ||||||
| Avg | 207.5M | 295.9M | ||||||
| Low | 178.0M | 214.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 271.4% | 83.5% | ||||||
| Avg | 229.8% | 42.6% | ||||||
| Low | 182.9% | 3.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.35 | - | ||||||
| Avg | -0.47 | -0.24 | ||||||
| Low | -0.90 | -0.57 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.